Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program

Olsson, L., Swedberg, K., Ducharme, A., Granger, C., Michelson, E., McMurray, J. , Puu, M., Yusuf, S., Pfeffer, M. and Investigators, C. (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program. Journal of the American College of Cardiology, 47, pp. 1997-2004. (doi:10.1016/j.jacc.2006.01.060)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Olsson, L., Swedberg, K., Ducharme, A., Granger, C., Michelson, E., McMurray, J., Puu, M., Yusuf, S., Pfeffer, M., and Investigators, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:Journal of the American College of Cardiology

University Staff: Request a correction | Enlighten Editors: Update this record